{
    "clinical_study": {
        "@rank": "85776", 
        "arm_group": [
            {
                "arm_group_label": "Placebo Syrup", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo Syrup 2.5 ml twice daily for 4 weeks"
            }, 
            {
                "arm_group_label": "Prospan Syrup", 
                "arm_group_type": "Active Comparator", 
                "description": "Prospan Syrup 2.5 ml twice daily for 4 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the effect of a prophylactical therapy with a cough medicine containing ivy\n      leaves dry extract on the frequency of recurrent wheezy bronchitis in toddlers, on the\n      duration of the bronchitis episodes, on the severity and the additional drug demand. A\n      prolonged asymptomatic episode between each wheezy bronchitis due to the therapy is assumed."
        }, 
        "brief_title": "Tolerance and Effect of a Prophylactical Treatment With Ivy Leaves Dry Extract in Recurrent Wheezy Bronchitis", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Acute Wheezy Bronchitis", 
            "Recurrent Bronchitis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bronchitis", 
                "Acute Disease", 
                "Asthma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Medical diagnosis of \u22653 episodes of wheezy bronchitis within the pre-vious 12 months\n\n          2. Children aged from 1 to 3 years (girls and boys)\n\n          3. Signed Informed Consent of the legal guardians to participate in the trial after\n             written and verbal briefing by the Investigator\n\n          4. No allergic sensitization\n\n          5. Allowance to contact the familys pediatrician for medical history of wheezy\n             bronchitis episodes\n\n        Exclusion Criteria:\n\n          1. Anamnestically known intolerance/allergy to one of the drugs applied or to their\n             ingredients or to drugs of similar chemical structure\n\n          2. Participation of the patient in another clinical trial within the last four weeks\n             before enrollment in this trial\n\n          3. Evidence suggesting that the patient or their legal representative is not likely to\n             follow the trial protocol (e.g. lacking compliance)\n\n          4. Inability to document the symptoms in a symptom log book or ques-tionnaire; inability\n             to take the trial medication properly\n\n          5. Any regular therapy except Vitamin D or Fluoride\n\n          6. Chronic illnesses of different aetiology\n\n          7. Premature birth or diagnosis of bronchopulmonary dysplasia\n\n          8. Gastro-oesophageal reflux\n\n          9. Hereditary fructose intolerance"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "3 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02045550", 
            "org_study_id": "HeHe02"
        }, 
        "intervention": {
            "arm_group_label": "Prospan Syrup", 
            "description": "2.5 ml twice daily for 4 weeks", 
            "intervention_name": "Prospan Syrup", 
            "intervention_type": "Drug", 
            "other_name": "Prospan Syrup"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 23, 2014", 
        "location": {
            "contact": {
                "email": "christian.vogelberg@uniklinikum-dresden.de", 
                "last_name": "Christian Vogelberg, MD PhD", 
                "phone": "0049351458", 
                "phone_ext": "2073"
            }, 
            "facility": {
                "address": {
                    "city": "Dresden", 
                    "country": "Germany", 
                    "state": "Saxonia", 
                    "zip": "01307"
                }, 
                "name": "Universit\u00e4tsklinikum Carl Gustav Carus, Klinik und Poliklinik f\u00fcr Kinder- und Jugendmedizin"
            }, 
            "investigator": [
                {
                    "last_name": "Sabine Zeil, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Christian Vogelberg, MD PhD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Tolerance and Effect of a Prophylactical Treatment With a Cough Medicine Con-taining Ivy Leaves Dry Extract in Children With Recurrent Wheezy Bronchitis", 
        "overall_contact": {
            "email": "christian.vogelberg@uniklinikum-dresden.de", 
            "last_name": "Christian Vogelberg, MD PhD", 
            "phone": "0049351458", 
            "phone_ext": "5699"
        }, 
        "overall_official": {
            "affiliation": "Technische Universit\u00e4t Dresden", 
            "last_name": "Christian Vogelberg, MD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "the time to event (next bronchitis episode) rate during and after treatment period", 
            "safety_issue": "No", 
            "time_frame": "three months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02045550"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "days and percentage of days without bronchitis during and after treatment period", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "days and percentage of days without bronchitis during treatment period", 
                "safety_issue": "No", 
                "time_frame": "three months"
            }
        ], 
        "source": "Technische Universit\u00e4t Dresden", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Technische Universit\u00e4t Dresden", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}